Attivitą Prestazioni Didattica Corsi Eventi Bandi Contatti
Istituto > Pubblicazioni > Anno 2003
Pubblicazioni Istituto inserite in PubMed e nell'Osservatorio della Ricerca - Anno 2003

Urbini B, Arpinati M, Bonifazi F, Chirumbolo G, Falcioni S, Stanzani M, Bandini G, Motta MR, Perrone G, Giannini B, Tura S, Baccarani M, Rondelli D. Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant. Exp Hematol. 2003 Oct;31(10):959-65.

Soverini S, Cavo M, Cellini C, Terragna C, Zamagni E, Ruggeri D, Testoni N, Tosi P, De Vivo A, Amabile M, Grafone T, Ottaviani E, Giannini B, Cangini D, Bonifazi F, Neri A, Fabris S, Tura S, Baccarani M, Martinelli G. Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. Blood. 2003 Sep 1;102(5):1588-94.

Zinzani PL, Tani M, Gabriele A, Gherlinzoni F, de Vivo A, Ricci P, Bandini G, Lemoli RM, Motta MR, Rizzi S, Giudice V, Zompatori M, Stefoni V, Alinari L, Musuraca G, Bassi S, Conte R, Pileri S, Tura S, Baccarani M. High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience. Haematologica. 2003 May;88(5):522-8.

Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G, Piccaluga PP, Malagola M, Testoni N, Rondoni M, Nucifora G, Tura S, Baccarani M. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. Haematologica. 2003 Nov;88(11):1221-8.

Zinzani PL, Tani M, Gabriele A, Poletti V, Stefoni V, Alinari L, Musuraca G, Bonifazi F, Pileri S, Tura S, Baccarani M. Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients. Leuk Lymphoma. 2003 May;44(5):821-4.

Martelli M, Gherlinzoni F, De Renzo A, Zinzani PL, De Vivo A, Cantonetti M, Falini B, Storti S, Meloni G, Rizzo M, Molinari AL, Lauria F, Moretti L, Lauta VM, Mazza P, Guardigni L, Pescarmona E, Pileri SA, Mandelli F, Tura S. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol. 2003 Apr 1;21(7):1255-62.

Zinzani PL, Carrillo G, Ascani S, Barbieri E, Tani M, Paulli M, Stefoni V, Sabattini E, Alinari L, Binazzi R, Tura S, Baccarani M, Pileri SA. Primary bone lymphoma: experience with 52 patients. Haematologica. 2003 Mar;88(3):280-5.

Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L, Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow. Bone Marrow Transplant. 2003 Jan;31(1):23-9.

Arpinati M, Terragna C, Chirumbolo G, Rizzi S, Urbini B, Re F, Tura S, Baccarani M, Rondelli D. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade. Exp Hematol. 2003 Jan;31(1):31-8.

Lemoli RM, Bertolini F, Petrucci MT, Gregorj C, Ricciardi MR, Fogli M, Curti A, Rabascio C, Pandolfi S, Ferrari S, Fo R, Baccarani M, Tafuri A. Functional and kinetic characterization of granulocyte colony-stimulating factor-primed CD34- human stem cells. Br J Haematol. 2003 Nov;123(4):720-729.

Zinzani PL, Stefoni V, Alinari L, Vianelli N, Baccarani M. Rituximab in heavily pretreated cutaneous B-cell lymphoma. Leuk Lymphoma. 2003 Sep;44(9):1637-8.

Baccarani M. Hematology on the web. Haematologica. 2003 Oct;88(10):1091.

Bianchini M, Ottaviani E, Grafone T, Giannini B, Soverini S, Terragna C, Amabile M, Piccaluga PP, Malagola M, Rondoni M, Bosi C, Baccarani M, Martinelli G. Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC. Clin Chem. 2003 Oct;49(10):1642-50.

Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini M, Visani G, Baccarani M. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature. Haematologica. 2003 Aug;88(8):ECR28.

Pea F, Russo D, Michieli M, Damiani D, Fanin R, Michelutti A, Michelutti T, Piccolrovazzi S, Baccarani M, Furlanut M. Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia. Clin Pharmacokinet. 2003;42(9):851-62.

Bonifazi F, Bandini G, Rondelli D, Falcioni S, Stanzani M, Bontadini A, Tazzari PL, Arpinati M, Giannini B, Conte R, Baccarani M. Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML. Bone Marrow Transplant. 2003 Aug;32(3):237-42.

Zinzani PL, Tani M, Barbieri E, Stefoni V, Alinari L, Baccarani M. Utility of surgical resection with or without radiation therapy in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Haematologica. 2003 Jul;88(7):830-1.

Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p210BCR-ABL tyrosine kinase. Haematologica. 2003 Jun;88(6):622-30.

Baccarani M. Comments on the Hammersmith policy. Semin Hematol. 2003 Apr;40(2 Suppl 3):104.

Rosti G, Testoni N, Martinelli G, Baccarani M. The cytogenetic response as a surrogate marker of survival. Semin Hematol. 2003 Apr;40(2 Suppl 3):56-61.

Zinzani PL, Alinari L, Stefoni V, Tani M, Baccarani M. Bilateral primary breast lymphoma: a case of local recurrence. Leuk Lymphoma. 2003 Apr;44(4):737-8.

Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A, Masolini P, Tomadini V, Tani M, Molinari AL, Baccarani M, Fanin R. B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica. 2003 May;88(5):538-46.

Bandini G, Bonifazi F, Baccarani M. 15 or 33 years of cord-blood transplantation? Lancet. 2003 May 3;361(9368):1566-7.

Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini A, Cellini C, Curti A, Gugliotta L, Visani G, Fanin R, Baccarani M. Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood. 2003 Sep 1;102(5):1595-600. Epub 2003 Apr 24.

Motta MR, Castellani S, Rizzi S, Curti A, Gubinelli F, Fogli M, Ferri E, Cellini C, Baccarani M, Lemoli RM. Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination. Br J Haematol. 2003 Apr;121(2):240-50.

Visani G, Piccaluga PP, Martinelli G, Rossi M, Malagola M, Baccarani M. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. clinical evidence of synergistic effect and real-time quantification of minimal residual disease. Haematologica. 2003 Apr;88(4):ELT15.

Rosti G, Trabacchi E, Bassi S, Bonifazi F, de Vivo A, Martinelli G, Alberti D, Fincato G, Saglio G, Baccarani M; Italian Cooperative Study Group on Chronic Myeloid Leukemia. Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia. Haematologica. 2003 Mar;88(3):256-9.

Martinelli G, Buonamici S, Visani G, Malagola M, Piccaluga PP, Isidori A, Bosi C, Bonifazi F, Soverini S, Terragna C, Amabile M, Giannini B, Baccarani M. Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely. Leukemia. 2003 Mar;17(3):650-1; author reply 651-2. No abstract available.

Rosti G, Bonifazi F, Trabacchi E, De Vivo A, Bassi S, Martinelli G, Testoni N, Russo D, Baccarani M. A phase II study of alpha-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia. Leukemia. 2003 Mar;17(3):554-9.

O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, GoldmanJM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003 Mar 13;348(11):994-1004.

Zinzani PL, Tani M, Alinari L, Stefoni V, Baccarani M. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? Leuk Res. 2003 May;27(5):465-6. No abstract available.

Damiani D, Stocchi R, Masolini P, Michelutti A, Geromin A, Sperotto A, Skert C, Michieli M, Baccarani M, Fanin R. CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection. Ann Oncol. 2003 Mar;14(3):475-80.

Baccarani M, Russo D, Rosti G, Martinelli G. Interferon-alfa for chronic myeloid leukemia. Semin Hematol. 2003 Jan;40(1):22-33. Review.

Hasford J, Pfirrmann M, Hehlmann R, Baccarani M, Guilhot F, Mahon FX, Kluin-Nelemans HC, Ohnishi K, Thaler J, Steegmann JL; Collaborative CML Prognostic Factors Project Group. Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy. Semin Hematol. 2003 Jan;40(1):4-12. Review.

Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, Michelutti A, Baccarani M, Fanin R, Ferraccioli G. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003 May 15;101(10):3827-34. Epub 2003 Jan 30.

Sola B, Troussard X, Soverini S, Martinelli G, Cavo M. Relevance of cyclin D1 level in the pathogenesis of multiple myeloma. Blood. 2003 Dec 1;102(12):4245-6. No abstract available.

Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I, Valagussa P, Boccadoro M, Samson D, Bacigalupo A, Russell N, Montefusco V, Voena C, Gahrton G; Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Blood. 2003 Sep 1;102(5):1927-9. Epub 2003 May 08.

Piccaluga PP, Visani G, Isidori A, Malagola M, Ascani S, Pileri SA. Microdose alpha-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report. Leukemia. 2003 May;17(5):986-7. No abstract available.

Martelli M, Gherlinzoni F, De Renzo A, Zinzani PL, De Vivo A, Cantonetti M, Falini B, Storti S, Meloni G, Rizzo M, Molinari AL, Lauria F, Moretti L, Lauta VM, Mazza P, Guardigni L, Pescarmona E, Pileri SA, Mandelli F, Tura S. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol. 2003 Apr 1;21(7):1255-62.

Marafioti T, Ascani S, Pulford K, Sabattini E, Piccioli M, Jones M, Zinzani PL, Delsol G, Mason DY, Pileri SA. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol. 2003 Mar;162(3):861-71.

Pileri SA, Sabattini E, Ascani S, Zinzani PL, Falini B. How do we define Hodgkin's disease? The authors' reply. J Clin Pathol. 2003 Feb;56(2):159. No abstract available.

Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, Pieri F, Berra E, Sabattini E, Ascani S, Piccioli M, Johnson PW, Giardini R, Pescarmona E, Novero D, Piccaluga PP, Marafioti T, Alonso MA, Cavalli F. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003 Jan;162(1):243-53.

Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, Patterson BJ, Ferreri AJ, Ponzoni M, Devizzi L, Giardini R, Pinotti G, Capella C, Zinzani PL, Pileri S, Lopez-Guillermo A, Campo E, Ambrosetti A, Baldini L, Cavalli F; International Extranodal Lymphoma Study Group. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003 Apr 1;101(7):2489-95. Epub 2002 Nov 27.

Zinzani PL. Complications of cytotoxic chemotherapy in older patients: focus on myelotoxicity in lymphomas. Crit Rev Oncol Hematol. 2003 Oct 15;48 Suppl:S27-31.

Zinzani PL. Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experience. Ann Oncol. 2003;14 Suppl 1:i43-5.

Piccaluga PP, Bianchini M, Martinelli G. Novel FLT3 point mutation in acute myeloid leukaemia. Lancet Oncol. 2003 Oct;4(10):604.

Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, Hughes G, Salamanchuk Z, Calasanz MJ, Lahortiga I, Pocock CF, Dang R, Fidler C, Wainscoat JS, Boultwood J, Cross NC. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. Br J Haematol. 2003 Jan;120(2):251-6.

Martinelli G, Piccaluga PP, Lo Coco F. FLT3 inhibition as tailored therapy for acute myeloid leukemia. Haematologica. 2003 Jan;88(1):4-8.

Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S, Parodi AM, Sergeant R, Martinetti M, Bontadini A, Bonifazi F, Lisini D, Mazzi B, Rossini S, Servida P, Ciceri F, Bonini C, Lanino E, Bandini G, Locatelli F, Apperley J, Bacigalupo A, Ferrara GB, Bordignon C, Fleischhauer K. A T cell epitope encoded by a subset of HLA-DPB1 alleles determines non-permissive mismatches for hematological stem cell transplantation. Blood. 2003 Oct 23

Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E, Ringden O, Ruutu T, Reiffers J, Bandini G, Falda M, Zikos P, Willemze R, Frassoni F; European Cooperative Group for Blood and Marrow Transplantation Acute Leukemia Working Party. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. Blood. 2003 Oct 15;102(8):3043-51.

Frumento G, Bacigalupo A, Lamparelli T, Lanino E, Delfino L, Morabito A, Parodi AM, Pera C, Pozzi S, Sormani MP, Bruzzi P, Colombo AA, Alessandrino P, Martinetti M, Bignon JD, Bandini G, Bontadini A, Marceno' R, Rambaldi A, Bontempelli M, Fuller T, Ferrara GB. Relevance of amino acid 116 substitutions on the outcome of hla class I mismatched bone marrow transplants. Hum Immunol. 2003 Oct;64(10 Suppl):S4. No abstract available.

Olavarria E, Ottmann OG, Deininger M, Clark RE, Bandini G, Byrne J, Lipton J, Vitek A, Michallet M, Siegert W, Ullmann A, Wassmann B, Niederwieser D, Fischer T; Chronic Leukaemia Working Party of the European Group of Bone and Marrow Transplantation (EBMT). Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia. 2003 Sep;17(9):1707-12.

Locasciulli A, Bruno B, Alessandrino EP, Meloni G, Arcese W, Bandini G, Cassibba V, Rotoli B, Morra E, Majolino I, Alberti A, Bacigalupo A; Italian Cooperative Group for Blood and Marrow Transplantation. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant. 2003 Feb;31(4):295-300.

Visani G, Mele A, Malagola M, Isidori A, Finelli C, Piccaluga PP. Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents. Leukemia. 2003 Aug;17(8):1669-70. No abstract available.

Arpinati M, Chirumbolo G, Urbini B, Perrone G, Rondelli D, Anasetti C. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol. 2003 Jul-Sep;11(3-4):345-56.

Storlazzi CT, Anelli L, Albano F, Zagaria A, Ventura M, Rocchi M, Panagopoulos I, Pannunzio A, Ottaviani E, Liso V, Specchia G. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. Ann Hematol. 2003 Oct 10 [Epub ahead of print]

Sola Brigitte, Troussard Xavier, Soverini Simona, Martinelli Giovanni, Cavo Michele. Relevance of cyclin D1 level in the pathogenesis of multiple myeloma. Blood. 2003 Dec; 102: 4245-4246.

Zinzani, P.L., Ascani, S., Sabattini, E., Stefoni, V., Binazzi, R., Pileri, S.A. Primary lymphomas of the bone. A clinico-pathologic study. Haematologica. 88:280-285, 2003.

Pileri, S.A., Zinzani, P.L., Gaidano, G.L., Falini, B., Gaulard, P, Zucca, E., Sabattini, E., Ascani, S., Cavalli, F., and the International Extranodal Lymphoma Study Group (IELSG). Pathobiology of primary mediastinal B-cell lymphoma. Leuk Lymphoma. 44 (Suppl 3):21-6, 2003.

Manfroi S, Bontadini A, Bonifazi F, Bandini G, Conte R. Hematopoietic mixed chimerism after allogenic BMT. Transfusion. 2003 Dec; 43(12): 1758-1759

Zaja F, Vianelli N, Sperotto A, Patriarca F, Tani M, Marin L, Tiribelli M, Candoni A, Baccarani M, Fanin R. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. Leuk Lymphoma. 2003 Nov;44(11):1951-5.

Istituto di Ematologia "Lorenzo e Ariosto Serągnoli" - Via Massarenti, 9 - 40138 Bologna - Tel. +39 051 636 3680 Fax +39 051 636 4037